Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for painful sensory neuropathy in primary Sjögren's syndrome
2024-517309-95-00Phase 3Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Oct 2024
- Countries
- 1
01
Overview
Phase 3, randomised trial in primary Sjögren's syndrome and peripheral neuropathy comparing Privigen with Placebo (2 arms). Primary endpoint: Clinical improvement at week 11. Started Oct 2024; status: completed.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
primary Sjögren's syndromeperipheral neuropathy
Beyond the preview
Go deeper on 2024-517309-95-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517309-95-00.